Valuation: AbbVie Inc.

Market Cap 463B 396B 370B 339B 637B 44,272B 650B 4,385B 1,709B 22,187B 1,737B 1,699B 73,454B P/E 2026 *
33.4x
P/E 2027 * 24.7x
Enterprise Value 523B 448B 418B 383B 721B 50,060B 735B 4,958B 1,933B 25,088B 1,964B 1,922B 83,058B EV / Sales 2026 *
7.74x
EV / Sales 2027 * 7x
Free-Float
95.71%
Yield 2026 *
2.62%
Yield 2027 * 2.75%
1 day-1.56%
1 week+4.39%
Current month+4.34%
1 month+3.33%
3 months+23.33%
6 months+16.47%
Current year+14.59%
1 week 248.31
Extreme 248.31
266.96
1 month 241.2
Extreme 241.2
267.47
Current year 190.75
Extreme 190.75
267.47
1 year 190.75
Extreme 190.75
267.47
3 years 135.85
Extreme 135.85
267.47
5 years 105.56
Extreme 105.56
267.47
10 years 55.06
Extreme 55.0623
267.47
Manager TitleAgeSince
Chief Executive Officer 55 01/07/2024
Director of Finance/CFO 59 23/06/2022
Chief Tech/Sci/R&D Officer - 01/03/2024
Director TitleAgeSince
Director/Board Member 65 01/01/2013
Director/Board Member 74 01/01/2013
Director/Board Member 69 01/01/2013
Date Insider Type Main position Quantity % Market Cap.
8/14/26 A Fiscal year

Executive/Senior Manager

98,130 0.0056%
6/30/26 A Free

Director

62 0.0000%
6/30/26 A Free

Director

134 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.56%+4.39%+25.19%+74.39% 463B
-2.81%+2.93%+76.40%+127.73% 1,109B
-2.21%+2.02%+49.50%+55.01% 644B
-1.51%+2.62%+41.69%+45.78% 371B
-0.92%+2.10%+23.43%+41.34% 301B
-0.80%+3.25%+0.94%+13.42% 256B
-1.95%+3.80%+46.31%+65.66% 234B
+0.60%-0.70%-14.31%-52.66% 205B
-2.82%+3.84%+20.81%+89.04% 178B
-1.59%+3.69%+9.50%-24.20% 158B
Average -1.56%+3.44%+27.95%+43.55% 391.95B
Weighted average by Cap. -1.89%+3.42%+41.89%+66.60%

Financials

2026 *2027 *
Net sales 67.58B 57.86B 53.99B 49.54B 93.09B 6,467B 94.92B 640B 250B 3,241B 254B 248B 10,729B 73.45B 62.89B 58.68B 53.84B 101B 7,028B 103B 696B 271B 3,522B 276B 270B 11,661B
Net income 13.86B 11.87B 11.07B 10.16B 19.09B 1,326B 19.47B 131B 51.21B 665B 52.05B 50.92B 2,201B 18.91B 16.19B 15.11B 13.86B 26.05B 1,810B 26.56B 179B 69.87B 907B 71.02B 69.47B 3,003B
Net Debt 60.49B 51.79B 48.32B 44.34B 83.32B 5,788B 84.96B 573B 223B 2,901B 227B 222B 9,603B 51.66B 44.23B 41.27B 37.87B 71.16B 4,943B 72.56B 490B 191B 2,477B 194B 190B 8,202B
Logo AbbVie Inc.
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.2%), Germany (2.8%), Japan (2.1%), Canada (2%), China (1.6%), France (1.3%), the United Kingdom (1%), Spain (1%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and Other (9.5%).
Employees
57,000
Date Price Change Volume
20/08/26 $261.83 -1.56% 5,228,907
19/08/26 $265.97 +2.72% 5,535,972
18/08/26 $258.92 +3.43% 5,010,229
17/08/26 $250.33 +0.35% 4,648,771
14/08/26 $249.46 -0.54% 4,195,386
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
261.83USD
Average target price
276.59USD
Spread / Average Target
+5.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABBV Stock